Find Leniolisib Phosphate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1354691-97-6, Leniolisib monophosphate, Joenja, Cdz173-az, 3700m1h39q, Cdz-173-az
Molecular Formula
C21H28F3N6O6P
Molecular Weight
548.5  g/mol
InChI Key
XXEDEGOAYSGNPS-ZOWNYOTGSA-N
FDA UNII
3700M1H39Q

Leniolisib Phosphate
LENIOLISIB PHOSPHATE is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2023 and is indicated for inborn error of immunity and has 2 investigational indications.
1 2D Structure

Leniolisib Phosphate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one;phosphoric acid
2.1.2 InChI
InChI=1S/C21H25F3N6O2.H3O4P/c1-3-18(31)30-6-4-13(10-30)28-19-15-11-29(7-5-17(15)26-12-27-19)14-8-16(21(22,23)24)20(32-2)25-9-14;1-5(2,3)4/h8-9,12-13H,3-7,10-11H2,1-2H3,(H,26,27,28);(H3,1,2,3,4)/t13-;/m0./s1
2.1.3 InChI Key
XXEDEGOAYSGNPS-ZOWNYOTGSA-N
2.2 Other Identifiers
2.2.1 UNII
3700M1H39Q
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1354691-97-6

2. Leniolisib Monophosphate

3. Joenja

4. Cdz173-az

5. 3700m1h39q

6. Cdz-173-az

7. Unii-3700m1h39q

8. Leniolisib (phosphate)

9. 1-propanone, 1-((3s)-3-((5,6,7,8-tetrahydro-6-(6-methoxy-5-(trifluoromethyl)-3-pyridinyl)pyrido(4,3-d)pyrimidin-4-yl)amino)-1-pyrrolidinyl)-, Phosphate (1:1)

10. Cdz-173

11. 1-[(3s)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5h-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one;phosphoric Acid

12. 1-((3s)-3-((6-(6-methoxy-5-(trifluoromethyl)pyrimidin-3-yl)-5,6,7,8-tetrahydropyrido(4,3-d)pyrimidin-4-yl)amino)pyrrolidin-1-yl)propan-1-one Phosphate

13. 1-[(3s)-3-({6-[6-methoxy-5-(trifluoromethyl)pyrimidin-3-yl]-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl}amino)pyrrolidin-1-yl]propan-1-one Phosphate

14. Joenja (tn)

15. Leniolisib Phosphate [who-dd]

16. Chembl3989909

17. Schembl15789519

18. Chebi:229650

19. Leniolisib Phosphate (jan/usan)

20. Xxedegoaysgnps-zownyotgsa-n

21. Leniolisib Phosphate [usan]

22. Hy-17635a

23. Akos040758719

24. Da-74950

25. Cs-0069337

26. D11159

27. Q27256604

28. (s)-1-(3-((6-(6-methoxy-5-(trifluoromethyl)pyridin-3-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)amino)pyrrolidin-1-yl)propan-1-one Phosphate

29. 1-[(3s)-3-({6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl}amino)pyrrolidin-1-yl]propan-1-one Phosphate

30. Phosphoric Acid--1-[(3s)-3-({6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl}amino)pyrrolidin-1-yl]propan-1-one (1/1)

2.3.2 Other Synonyms

1. Leniolisib

2.4 Create Date
2015-02-13
3 Chemical and Physical Properties
Molecular Weight 548.5 g/mol
Molecular Formula C21H28F3N6O6P
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count14
Rotatable Bond Count5
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area161
Heavy Atom Count37
Formal Charge0
Complexity703
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 1354691-97-6 / Leniolisib Phosphate API manufacturers, exporters & distributors?

Leniolisib Phosphate manufacturers, exporters & distributors 1

93

PharmaCompass offers a list of Leniolisib Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Leniolisib Phosphate manufacturer or Leniolisib Phosphate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Leniolisib Phosphate manufacturer or Leniolisib Phosphate supplier.

PharmaCompass also assists you with knowing the Leniolisib Phosphate API Price utilized in the formulation of products. Leniolisib Phosphate API Price is not always fixed or binding as the Leniolisib Phosphate Price is obtained through a variety of data sources. The Leniolisib Phosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Leniolisib Phosphate

Synonyms

1354691-97-6, Leniolisib monophosphate, Joenja, Cdz173-az, 3700m1h39q, Cdz-173-az

Cas Number

1354691-97-6

Unique Ingredient Identifier (UNII)

3700M1H39Q

About Leniolisib Phosphate

LENIOLISIB PHOSPHATE is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2023 and is indicated for inborn error of immunity and has 2 investigational indications.

Leniolisib Phosphate Manufacturers

A Leniolisib Phosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Leniolisib Phosphate, including repackagers and relabelers. The FDA regulates Leniolisib Phosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Leniolisib Phosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Leniolisib Phosphate Suppliers

A Leniolisib Phosphate supplier is an individual or a company that provides Leniolisib Phosphate active pharmaceutical ingredient (API) or Leniolisib Phosphate finished formulations upon request. The Leniolisib Phosphate suppliers may include Leniolisib Phosphate API manufacturers, exporters, distributors and traders.

Leniolisib Phosphate GMP

Leniolisib Phosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Leniolisib Phosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Leniolisib Phosphate GMP manufacturer or Leniolisib Phosphate GMP API supplier for your needs.

Leniolisib Phosphate CoA

A Leniolisib Phosphate CoA (Certificate of Analysis) is a formal document that attests to Leniolisib Phosphate's compliance with Leniolisib Phosphate specifications and serves as a tool for batch-level quality control.

Leniolisib Phosphate CoA mostly includes findings from lab analyses of a specific batch. For each Leniolisib Phosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Leniolisib Phosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Leniolisib Phosphate EP), Leniolisib Phosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Leniolisib Phosphate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty